Literature DB >> 21825219

AMP activated protein kinase-α2 regulates expression of estrogen-related receptor-α, a metabolic transcription factor related to heart failure development.

Xinli Hu1, Xin Xu, Zhongbing Lu, Ping Zhang, John Fassett, Ying Zhang, Yi Xin, Jennifer L Hall, Benoit Viollet, Robert J Bache, Yimin Huang, Yingjie Chen.   

Abstract

The normal expression of myocardial mitochondrial enzymes is essential to maintain the cardiac energy reserve and facilitate responses to stress, but the molecular mechanisms to maintain myocardial mitochondrial enzyme expression have been elusive. Here we report that congestive heart failure is associated with a significant decrease of myocardial estrogen-related receptor-α (ERRα), but not peroxisome proliferator-activated receptor-γ coactivator 1α, in human heart failure samples. In addition, chronic pressure overload in mice caused a decrease of ERRα expression that was significantly correlated to the degree of left ventricular dysfunction, pulmonary congestion, and decreases of a group of myocardial energy metabolism-related genes. We found that the metabolic sensor AMP activated protein kinase (AMPK) regulates ERRα expression in vivo and in vitro. AMPKα2 knockout decreased myocardial ERRα (both mRNA and protein) and its downstream targets under basal conditions, with no change in myocardial peroxisome proliferator-activated receptor-γ coactivator 1α expression. Using cultured rat neonatal cardiac myocytes, we found that overexpression of constitutively active AMPKα significantly induced ERRα mRNA, protein, and promoter activity. Conversely, selective gene silencing of AMPKα2 repressed ERRα and its target gene levels, indicating that AMPKα2 is involved in the regulation of ERRα expression. In addition, overexpression of ERRα in AMPKα2 knockout neonatal cardiac myocytes partially rescued the repressed expression of some energy metabolism-related genes. These data support an important role for AMPKα2 in regulating the expression of myocardial ERRα and its downstream mitochondrial enzymes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825219      PMCID: PMC3182261          DOI: 10.1161/HYPERTENSIONAHA.111.174128

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  42 in total

1.  Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression.

Authors:  Yi Zhang; Ke Ma; Prabodh Sadana; Farhana Chowdhury; Stephanie Gaillard; Fang Wang; Donald P McDonnell; Terry G Unterman; Marshall B Elam; Edwards A Park
Journal:  J Biol Chem       Date:  2006-11-01       Impact factor: 5.157

2.  Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesis.

Authors:  Josep A Villena; M Benjamin Hock; William Y Chang; Joanalyn E Barcas; Vincent Giguère; Anastasia Kralli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

3.  RIP140 expression is stimulated by estrogen-related receptor alpha during adipogenesis.

Authors:  Donna Nichol; Mark Christian; Jennifer H Steel; Roger White; Malcolm G Parker
Journal:  J Biol Chem       Date:  2006-08-21       Impact factor: 5.157

4.  Interplay between estrogen-related receptor alpha (ERRalpha) and gamma (ERRgamma) on the regulation of ERRalpha gene expression.

Authors:  Zhiping Zhang; Christina T Teng
Journal:  Mol Cell Endocrinol       Date:  2006-12-08       Impact factor: 4.102

5.  Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy.

Authors:  R Tian; N Musi; J D'Agostino; M F Hirshman; L J Goodyear
Journal:  Circulation       Date:  2001-10-02       Impact factor: 29.690

6.  Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms.

Authors:  Sabyasachi Sanyal; Joon-Young Kim; Han-Jong Kim; Jun Takeda; Yoon-Kwang Lee; David D Moore; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2001-11-08       Impact factor: 5.157

7.  ERRalpha regulates osteoblastic and adipogenic differentiation of mouse bone marrow mesenchymal stem cells.

Authors:  Ann-Marie Rajalin; Hanna Pollock; Piia Aarnisalo
Journal:  Biochem Biophys Res Commun       Date:  2010-04-24       Impact factor: 3.575

8.  The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

Authors:  Benoit Viollet; Fabrizio Andreelli; Sebastian B Jørgensen; Christophe Perrin; Alain Geloen; Daisy Flamez; James Mu; Claudia Lenzner; Olivier Baud; Myriam Bennoun; Emmanuel Gomas; Gaël Nicolas; Jørgen F P Wojtaszewski; Axel Kahn; David Carling; Frans C Schuit; Morris J Birnbaum; Erik A Richter; Rémy Burcelin; Sophie Vaulont
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

9.  Identification of a specific molecular repressor of the peroxisome proliferator-activated receptor gamma Coactivator-1 alpha (PGC-1alpha).

Authors:  Masaru Ichida; Shino Nemoto; Toren Finkel
Journal:  J Biol Chem       Date:  2002-10-22       Impact factor: 5.157

10.  The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha).

Authors:  Sylvia N Schreiber; Darko Knutti; Kathrin Brogli; Thomas Uhlmann; Anastasia Kralli
Journal:  J Biol Chem       Date:  2003-01-08       Impact factor: 5.157

View more
  38 in total

Review 1.  Mitochondrial Dynamics and Heart Failure.

Authors:  A A Knowlton; T T Liu
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

2.  CHIP protects against cardiac pressure overload through regulation of AMPK.

Authors:  Jonathan C Schisler; Carrie E Rubel; Chunlian Zhang; Pamela Lockyer; Douglas M Cyr; Cam Patterson
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

Review 3.  Heart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategies.

Authors:  Anne A Knowlton; Le Chen; Zulfiqar A Malik
Journal:  J Cardiovasc Pharmacol       Date:  2014-03       Impact factor: 3.105

4.  Estrogen-related receptor α (ERRα) and ERRγ are essential coordinators of cardiac metabolism and function.

Authors:  Ting Wang; Caitlin McDonald; Nataliya B Petrenko; Mathias Leblanc; Tao Wang; Vincent Giguere; Ronald M Evans; Vickas V Patel; Liming Pei
Journal:  Mol Cell Biol       Date:  2015-01-26       Impact factor: 4.272

Review 5.  AMP-activated protein kinase regulation and biological actions in the heart.

Authors:  Vlad G Zaha; Lawrence H Young
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

6.  Maintaining PGC-1α expression following pressure overload-induced cardiac hypertrophy preserves angiogenesis but not contractile or mitochondrial function.

Authors:  Renata O Pereira; Adam R Wende; Ashley Crum; Douglas Hunter; Curtis D Olsen; Tenley Rawlings; Christian Riehle; Walter F Ward; E Dale Abel
Journal:  FASEB J       Date:  2014-04-28       Impact factor: 5.191

Review 7.  PGC-1 proteins and heart failure.

Authors:  Christian Riehle; E Dale Abel
Journal:  Trends Cardiovasc Med       Date:  2012-08-29       Impact factor: 6.677

8.  17-β estradiol attenuates ovariectomy-induced changes in cardiomyocyte contractile function via activation of AMP-activated protein kinase.

Authors:  Subat Turdi; Anna F Huff; Jiaojiao Pang; Emily Y He; Xiyao Chen; Shuyi Wang; Yuguo Chen; Yingmei Zhang; Jun Ren
Journal:  Toxicol Lett       Date:  2014-11-13       Impact factor: 4.372

Review 9.  Mitochondria as a therapeutic target in heart failure.

Authors:  Marina Bayeva; Mihai Gheorghiade; Hossein Ardehali
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

10.  Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2.

Authors:  Xin Xu; Zhongbing Lu; John Fassett; Ping Zhang; Xinli Hu; Xiaoyu Liu; Dongmin Kwak; Jingxin Li; Guangshuo Zhu; Yi Tao; Mingxiao Hou; Huan Wang; Haipeng Guo; Benoit Viollet; Edward O McFalls; Robert J Bache; Yingjie Chen
Journal:  Hypertension       Date:  2014-01-13       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.